Cargando…
Assessing and monitoring the impact of the national newborn hearing screening program in Israel
BACKGROUND: The Israeli Newborn Hearing Screening Program (NHSP) began operating nationally in January 2010. The program includes the Otoacoustic Emissions (OAE) test for all newborns and Automated Auditory Brainstem Response (A-ABR) test for failed OAE and infants at risk for auditory neuropathy sp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410489/ https://www.ncbi.nlm.nih.gov/pubmed/30857547 http://dx.doi.org/10.1186/s13584-019-0296-6 |
_version_ | 1783402253314424832 |
---|---|
author | Wasser, Janice Ari-Even Roth, Daphne Herzberg, Orly Lerner-Geva, Liat Rubin, Lisa |
author_facet | Wasser, Janice Ari-Even Roth, Daphne Herzberg, Orly Lerner-Geva, Liat Rubin, Lisa |
author_sort | Wasser, Janice |
collection | PubMed |
description | BACKGROUND: The Israeli Newborn Hearing Screening Program (NHSP) began operating nationally in January 2010. The program includes the Otoacoustic Emissions (OAE) test for all newborns and Automated Auditory Brainstem Response (A-ABR) test for failed OAE and infants at risk for auditory neuropathy spectrum disorders. NHSP targets are diagnosis of hearing impairment by age three months and initiation of habilitation by six months. OBJECTIVES: (1) Review NHSP coverage; (2) Assess NHSP impact on age at diagnosis for hearing impairment and age at initiation of habilitation; (3) Identify contributing factors and barriers to NHSP success. METHODS: (1) Analysis of screening coverage and referral rates for the NHSP; (2) Analysis of demographic data, results of coverage, age at diagnosis and initiation of habilitation for hearing impaired infants pre-implementation and post-implementation of NHSP from 10 habilitation centers; (3) Telephone interviews with parents whose infants failed the screening and were referred for further testing. RESULTS: The NHSP coverage was 98.7% (95.1 to 100%) for approximately 179,000 live births per year for 2014–2016 and average referral rates were under 3%. After three years of program implementation, median age at diagnosis was 3.7 months compared to 9.5 months prior to NHSP. The median age at initiation of habilitation after three years of NHSP was 9.4 months compared to 19.0 prior to NHSP. Parents (84% of 483 sampled) with infants aged 4–6 months participated in the telephone survey. While 84% of parents reported receiving a verbal explanation of the screening results, more than half of the parents reported not receiving written material. Parental report of understanding the test results and a heightened level of concern over the failed screen were associated with timely follow-up. CONCLUSIONS: The findings indicate high screening coverage. The program reduced ages at diagnosis and initiation of habilitation for hearing impaired infants. Further steps needed to streamline the NHSP are improving communication among caregivers to parents to reduce anxiety; increasing efficiency in transferring information between service providers using advanced technology while ensuring continuum of care; reducing wait time for follow-up testing in order to meet program objectives. Establishment of a routine monitoring system is underway. |
format | Online Article Text |
id | pubmed-6410489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-64104892019-03-21 Assessing and monitoring the impact of the national newborn hearing screening program in Israel Wasser, Janice Ari-Even Roth, Daphne Herzberg, Orly Lerner-Geva, Liat Rubin, Lisa Isr J Health Policy Res Original Research Article BACKGROUND: The Israeli Newborn Hearing Screening Program (NHSP) began operating nationally in January 2010. The program includes the Otoacoustic Emissions (OAE) test for all newborns and Automated Auditory Brainstem Response (A-ABR) test for failed OAE and infants at risk for auditory neuropathy spectrum disorders. NHSP targets are diagnosis of hearing impairment by age three months and initiation of habilitation by six months. OBJECTIVES: (1) Review NHSP coverage; (2) Assess NHSP impact on age at diagnosis for hearing impairment and age at initiation of habilitation; (3) Identify contributing factors and barriers to NHSP success. METHODS: (1) Analysis of screening coverage and referral rates for the NHSP; (2) Analysis of demographic data, results of coverage, age at diagnosis and initiation of habilitation for hearing impaired infants pre-implementation and post-implementation of NHSP from 10 habilitation centers; (3) Telephone interviews with parents whose infants failed the screening and were referred for further testing. RESULTS: The NHSP coverage was 98.7% (95.1 to 100%) for approximately 179,000 live births per year for 2014–2016 and average referral rates were under 3%. After three years of program implementation, median age at diagnosis was 3.7 months compared to 9.5 months prior to NHSP. The median age at initiation of habilitation after three years of NHSP was 9.4 months compared to 19.0 prior to NHSP. Parents (84% of 483 sampled) with infants aged 4–6 months participated in the telephone survey. While 84% of parents reported receiving a verbal explanation of the screening results, more than half of the parents reported not receiving written material. Parental report of understanding the test results and a heightened level of concern over the failed screen were associated with timely follow-up. CONCLUSIONS: The findings indicate high screening coverage. The program reduced ages at diagnosis and initiation of habilitation for hearing impaired infants. Further steps needed to streamline the NHSP are improving communication among caregivers to parents to reduce anxiety; increasing efficiency in transferring information between service providers using advanced technology while ensuring continuum of care; reducing wait time for follow-up testing in order to meet program objectives. Establishment of a routine monitoring system is underway. BioMed Central 2019-03-11 /pmc/articles/PMC6410489/ /pubmed/30857547 http://dx.doi.org/10.1186/s13584-019-0296-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Research Article Wasser, Janice Ari-Even Roth, Daphne Herzberg, Orly Lerner-Geva, Liat Rubin, Lisa Assessing and monitoring the impact of the national newborn hearing screening program in Israel |
title | Assessing and monitoring the impact of the national newborn hearing screening program in Israel |
title_full | Assessing and monitoring the impact of the national newborn hearing screening program in Israel |
title_fullStr | Assessing and monitoring the impact of the national newborn hearing screening program in Israel |
title_full_unstemmed | Assessing and monitoring the impact of the national newborn hearing screening program in Israel |
title_short | Assessing and monitoring the impact of the national newborn hearing screening program in Israel |
title_sort | assessing and monitoring the impact of the national newborn hearing screening program in israel |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410489/ https://www.ncbi.nlm.nih.gov/pubmed/30857547 http://dx.doi.org/10.1186/s13584-019-0296-6 |
work_keys_str_mv | AT wasserjanice assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael AT arievenrothdaphne assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael AT herzbergorly assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael AT lernergevaliat assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael AT rubinlisa assessingandmonitoringtheimpactofthenationalnewbornhearingscreeningprograminisrael |